Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. [electronic resource]
Producer: 20060207Description: 765-72 p. digitalISSN:- 0020-7136
- Adult
- Animals
- Antineoplastic Agents -- therapeutic use
- Apoptosis -- drug effects
- CDC2 Protein Kinase -- metabolism
- Cell Cycle -- drug effects
- Cell Cycle Proteins -- metabolism
- Cell Proliferation -- drug effects
- Curcumin -- therapeutic use
- Cyclin D1 -- metabolism
- Female
- Gene Products, tax -- pharmacology
- Human T-lymphotropic virus 1 -- drug effects
- Humans
- Inhibitor of Apoptosis Proteins
- Leukemia, T-Cell -- drug therapy
- Leukemia-Lymphoma, Adult T-Cell -- drug therapy
- Mice
- Mice, Inbred ICR
- Mice, SCID
- Microtubule-Associated Proteins -- metabolism
- NF-kappa B -- antagonists & inhibitors
- Neoplasm Proteins -- metabolism
- Survivin
- T-Lymphocytes -- drug effects
- Tumor Cells, Cultured
- X-Linked Inhibitor of Apoptosis Protein -- metabolism
- cdc25 Phosphatases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.